Clarivate Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Clarivate wird ein jährliches Gewinn- und Umsatzwachstum von 103.9% bzw. 2.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 108% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.1% betragen.
Wichtige Informationen
95.3%
Wachstumsrate der Gewinne
98.9%
EPS-Wachstumsrate
| Professional Services Gewinnwachstum | 17.9% |
| Wachstumsrate der Einnahmen | 2.9% |
| Zukünftige Eigenkapitalrendite | 8.7% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 12 Sep 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Here's Why Clarivate (NYSE:CLVT) Has A Meaningful Debt Burden
Sep 27
Clarivate Plc (NYSE:CLVT) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Sep 06Is Clarivate Plc (NYSE:CLVT) Trading At A 43% Discount?
Aug 29Clarivate: Attractive Upside Even With Conservative Assumptions
Aug 09Clarivate Plc's (NYSE:CLVT) Price Is Out Of Tune With Revenues
Jul 02Clarivate (NYSE:CLVT) Has A Somewhat Strained Balance Sheet
Jun 05Clarivate Plc: Still A Buy, But Recovery Could Take Longer Than Expected
May 30Is Clarivate Plc (NYSE:CLVT) Trading At A 38% Discount?
Apr 25Clarivate PLC: Agree Q4'23 Was Weak, But The Upside Remains Attractive
Mar 14Risks Still Elevated At These Prices As Clarivate Plc (NYSE:CLVT) Shares Dive 25%
Mar 13Clarivate: Leverage And Underperformance Overhang Continues
Mar 04Here's Why Clarivate (NYSE:CLVT) Has A Meaningful Debt Burden
Feb 23What Is Clarivate Plc's (NYSE:CLVT) Share Price Doing?
Feb 02Clarivate Plc's (NYSE:CLVT) Intrinsic Value Is Potentially 51% Above Its Share Price
Jan 12Clarivate Plc's (NYSE:CLVT) 27% Price Boost Is Out Of Tune With Revenues
Dec 22Clarivate: Rating Upgrade As Organic Growth Turns Positive
Dec 18Clarivate (NYSE:CLVT) Takes On Some Risk With Its Use Of Debt
Nov 21Clarivate: In Search Of Growth
Nov 08At US$7.04, Is It Time To Put Clarivate Plc (NYSE:CLVT) On Your Watch List?
Sep 08Is Clarivate (NYSE:CLVT) A Risky Investment?
Aug 21Clarivate: Business Has To Show Positive Organic Growth To Convince The Market
Aug 17It's Down 28% But Clarivate Plc (NYSE:CLVT) Could Be Riskier Than It Looks
Aug 05Are Investors Undervaluing Clarivate Plc (NYSE:CLVT) By 46%?
Aug 02Clarivate: Business On Track To Hit Mid-Single Digits Organic Growth
Jun 29Clarivate (NYSE:CLVT) Seems To Use Debt Quite Sensibly
May 16Is Clarivate Plc (NYSE:CLVT) Trading At A 29% Discount?
Apr 25We Think Clarivate (NYSE:CLVT) Is Taking Some Risk With Its Debt
Jan 31Clarivate: Attractive Business Model With Improving Organic Growth
Jan 25Is There An Opportunity With Clarivate Plc's (NYSE:CLVT) 48% Undervaluation?
Jan 10Clarivate decreases board size
Dec 20Clarivate Analytics reports mixed Q3 earnings; narrows FY22 guidance
Nov 08Checking Out Clarivate
Oct 18Clarivate (NYSE:CLVT) Has A Somewhat Strained Balance Sheet
Sep 26Newfold Digital to acquire MarkMonitor from Clarivate for $302.5M
Sep 12Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 2,769 | 91 | 515 | 817 | 6 |
| 12/31/2025 | 2,663 | 6 | 450 | 756 | 9 |
| 12/31/2024 | 2,606 | -336 | 421 | 698 | 9 |
| 6/30/2024 | 2,602 | -1,280 | 401 | 657 | N/A |
| 3/31/2024 | 2,621 | -1,105 | 445 | 693 | N/A |
| 12/31/2023 | 2,629 | -987 | 502 | 744 | N/A |
| 9/30/2023 | 2,620 | 181 | 465 | 690 | N/A |
| 6/30/2023 | 2,609 | -4,247 | 504 | 735 | N/A |
| 3/31/2023 | 2,627 | -4,062 | 449 | 669 | N/A |
| 12/31/2022 | 2,660 | -4,036 | 306 | 509 | N/A |
| 9/30/2022 | 2,545 | -4,470 | 202 | 391 | N/A |
| 6/30/2022 | 2,352 | -30 | 81 | 227 | N/A |
| 3/31/2022 | 2,111 | -205 | 90 | 217 | N/A |
| 12/31/2021 | 1,877 | -312 | 205 | 324 | N/A |
| 9/30/2021 | 1,772 | -195 | 326 | 441 | N/A |
| 6/30/2021 | 1,614 | -383 | 301 | 418 | N/A |
| 3/31/2021 | 1,442 | -277 | 264 | 391 | N/A |
| 12/31/2020 | 1,254 | -351 | 156 | 264 | N/A |
| 9/30/2020 | 1,053 | -469 | 22 | 133 | N/A |
| 6/30/2020 | 1,012 | -277 | 76 | 182 | N/A |
| 3/31/2020 | 981 | -329 | 35 | 121 | N/A |
| 12/31/2019 | 974 | -259 | 45 | 118 | N/A |
| 9/30/2019 | 965 | -170 | 6 | 61 | N/A |
| 6/30/2019 | 964 | -235 | -60 | -14 | N/A |
| 3/31/2019 | 965 | -224 | -60 | -22 | N/A |
| 12/31/2018 | 968 | -242 | -72 | -26 | N/A |
| 12/31/2017 | 918 | -264 | N/A | 7 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CLVT wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.4%).
Ertrag vs. Markt: CLVT wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: CLVT wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: CLVTDie Einnahmen des Unternehmens (2.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: CLVTDie Einnahmen des Unternehmens (2.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CLVTDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.1%).